Rosetta Genomics Ltd.

Rosetta Genomics Ltd.

Rosetta Genomics Ltd. was founded in 2000 and is based in Rehovot, Israel.Rosetta Genomics Ltd. develops microRNA-based diagnostic and therapeutic products in Israel. MicroRNAs are naturally expressed, or produced, using instructions encoded in DNA and are used in regulating protein production. The company develops microRNA-based diagnostic programs for various cancers, as well as for the identification of the origin of the primary tumor of metastases; for differentiating squamous from non squamous non-small cell lung cancer; and for differentiating mesothelioma from other carcinomas in the lung and pleura. The company also focuses on the development of minimally/non-invasive, blood or serum-based molecular diagnostics tests. In addition, it develops microRNA-based therapeutic products for the treatment of liver cancer and chronic infections. The company has a license and collaboration agreement with Prometheus Laboratories Inc. to license and sublicense certain rights related to the company's microRNA-based cancer diagnostic tests; and a testing and administrative services agreement with Teva Pharmaceutical Industries Ltd. to distribute these tests in Turkey and Israel.

Contact Details

Office Address

Rosetta Genomics Ltd.
10 Plaut Street
Rehovot, Israel 76706
Phone: +972-73-222-0700
Fax: +972-73-222-0701

Executives

Founder & Chief Architect

Dr. Isaac Bentwich

Chief Exec. Officer

Mr. Kenneth A. Berlin

Business Reviews for Rosetta Genomics Ltd.

Related Companies